EIF5A1 up-regulated in several malignancies, including colorectal carcinoma, lung adenocarcinoma, and glioblastoma [100]; for that reason, EIF5A1 is considered a tumour promoter (oncogene). This evidence concerns the gene EIF5A and neoplasm.